Health Canada-DEA Approves MMJ International Holdings To Ship THC
MMJ will be utilizing its new product for an FDA approved treatment for multiple sclerosis (MS) and Huntington's disease (HD). It also received the US Drug Enforcement Agency's approval to...(PRWeb February 20, 2020)Read the full story at https://www.prweb.com/releases/health_canada_dea_approves_mmj_international_holdings_to_ship_thc/prweb16927573.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 20, 2020 Category: Pharmaceuticals Source Type: news

Spanish modified Story Memory Technique efficacious for Mexicans with multiple sclerosis
(Kessler Foundation) Researchers adapted the English language Kessler Foundation modified Story Memory Technique into Spanish. 'This is an example of how cultural adaptation can extend evidence-based interventions to non-English speaking populations,' said Dr. Krch. 'The positive outcomes of this pilot study of urban-based Mexicans have important implications. While further testing is needed, we anticipate that this adaptation of the modified Story Memory Technique will be applicable to the diverse Spanish-speaking population in the US, in addition to those with Mexican heritage.' (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 19, 2020 Category: International Medicine & Public Health Source Type: news

Mylan loses patent battle to pharma rival
A patent board has turned back an initiative by Mylan NV over a drug to treat multiple sclerosis. The Street reported the U.S. Patent Office said Mylan (Nasdaq: MYL) hadn't proven its case about the active ingredient in Tecidera, which is made by Biogen (Nasdaq: BIIB). Mylan, which told The Street it was considering an appeal, had filed a patent challenge about Tecidera. Tecidera is a main rev enue driver for Biogen, accounting for 30 percent of its revenue in 2019, $4.43 billion. Mylan is also… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 10, 2020 Category: Biotechnology Authors: Paul J. Gough Source Type: news

Roche provides topline results from investigator-led Phase II/III trial with gantenerumab in rare inherited form of Alzheimer ’s disease
Basel, 10 February 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the gantenerumab arm of the Phase II/III DIAN-TU-001 study did not meet its primary endpoint in people who have an early-onset, inherited form of Alzheimer ’s disease (AD). This form of AD, known as autosomal dominant AD (ADAD), accounts for less than 1% of all cases of the disease.1 The study, sponsored by Washington University School of Medicine in St. Louis, US, did not show a significant slowing of the rate of cognitive decline in people treated with investigational medicine gantenerumab as measured by the novel DIAN Multivariate Co...
Source: Roche Media News - February 10, 2020 Category: Pharmaceuticals Source Type: news

Roche provides topline results from investigator-led Phase II/III trial with gantenerumab in rare inherited form of Alzheimer ’s disease
Basel, 10 February 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the gantenerumab arm of the Phase II/III DIAN-TU-001 study did not meet its primary endpoint in people who have an early-onset, inherited form of Alzheimer ’s disease (AD). This form of AD, known as autosomal dominant AD (ADAD), accounts for less than 1% of all cases of the disease.1 The study, sponsored by Washington University School of Medicine in St. Louis, US, did not show a significant slowing of the rate of cognitive decline in people treated with investigational medicine gantenerumab as measured by the novel DIAN Multivariate Co...
Source: Roche Investor Update - February 10, 2020 Category: Pharmaceuticals Source Type: news

Sanofi brain-penetrant BTK inhibitor meets primary endpoint of Phase 2 trial in relapsing multiple sclerosis
The Sanofi Phase 2b study evaluating its investigational BTK (Bruton's tyrosine kinase) inhibitor (SAR442168), an oral, brain-penetrant, selective small molecule, achieved its primary endpoint. In the trial, SAR442168 significantly reduced disease activity associated with multiple sclerosis (MS) as measured by magnetic resonance imaging (MRI). (Source: World Pharma News)
Source: World Pharma News - February 7, 2020 Category: Pharmaceuticals Tags: Featured Sanofi Business and Industry Source Type: news

Biogen shares soar 32% on MS drug patent win over Mylan
Biogen Inc's shares surged as much as 32% on Wednesday after the drugmaker won a favorable U.S. patent ruling for its main multiple sclerosis drug Tecfidera in a battle with Mylan NV. (Source: Reuters: Health)
Source: Reuters: Health - February 6, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Biogen shares soar after patent victory
Mylan had lodged dispute over a drug for multiple sclerosis (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - February 5, 2020 Category: Pharmaceuticals Source Type: news

Lab Discovery Offers Promise for Treating Multiple Sclerosis
WEDNESDAY, Feb. 5, 2020 -- A new discovery could lead to better treatments for multiple sclerosis (MS) and other autoimmune diseases, such as psoriasis and rheumatoid arthritis, researchers report. MS occurs when immune cells get into the central... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 5, 2020 Category: General Medicine Source Type: news

High-Tech'Exoskeleton' Can Give Mobility Back to People With MS
TUESDAY, Feb. 4, 2020 -- Most people take the ability to move for granted, but not Kathy Miska. Miska has had multiple sclerosis for two decades now, and her ability to get around has deteriorated steadily. Now, a new robotic exoskeleton is giving... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 4, 2020 Category: General Medicine Source Type: news

Cladribine Oral Tablets (10mg) for Multiple Sclerosis
Title: Cladribine Oral Tablets (10mg) for Multiple SclerosisCategory: MedicationsCreated: 2/4/2020 12:00:00 AMLast Editorial Review: 2/4/2020 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - February 4, 2020 Category: Drugs & Pharmacology Source Type: news

Dietary interventions may slow onset of inflammatory and autoimmune disorders
(Van Andel Research Institute) Significantly reducing dietary levels of the amino acid methionine could slow onset and progression of inflammatory and autoimmune disorders such as multiple sclerosis in high-risk individuals, according to findings published today in Cell Metabolism. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 4, 2020 Category: Biology Source Type: news

Multiple sclerosis: prevalence, incidence and smoking status
Public Health England has published analysis of primary care records relating to diagnosed cases of multiple sclerosis in England. (Source: NHS Networks)
Source: NHS Networks - February 4, 2020 Category: UK Health Source Type: news

Road Proximity Linked to Incidence of Neurologic Diseases
Incidence increased for non - Alzheimer dementia, Parkinson, Alzheimer disease, multiple sclerosis (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - February 1, 2020 Category: Psychiatry Tags: Family Medicine, Internal Medicine, Neurology, Psychiatry, Journal, Source Type: news

Early Treatment Tied to Less Disability With Pediatric-Onset MS
FRIDAY, Jan. 31, 2020 -- Timing of treatment start is an important predictor of disability accumulation in patients with pediatric-onset multiple sclerosis (MS), according to a study published online Jan. 17 in Multiple Sclerosis and Related... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 31, 2020 Category: Pharmaceuticals Source Type: news

Comorbidities Tied to Higher Rates of All - Cause Admissions in MS Patients
But comorbidities not associated with increased hospitalizations related to multiple sclerosis (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - January 30, 2020 Category: Psychiatry Tags: Cardiology, Endocrinology, Neurology, Psychiatry, Pulmonology, Journal, Source Type: news

Biogen's multiple sclerosis drug powers quarterly profit beat
Biogen Inc's top-selling multiple sclerosis drug helped the company's quarterly profit beat market expectations on Thursday, sending its shares up about 2% before the bell. (Source: Reuters: Health)
Source: Reuters: Health - January 30, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Comorbidities Tied to Higher Rates of All-Cause Admissions in MS Patients
THURSDAY, Jan. 30, 2020 -- Comorbidities increase the rate of all-cause, but not multiple sclerosis (MS)-specific, hospital admissions among patients with MS, according to a study published online Jan. 21 in Multiple Sclerosis and Related... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 30, 2020 Category: Pharmaceuticals Source Type: news

Immune response in brain, spinal cord could offer clues to treating neurological diseases
(University of Alberta Faculty of Medicine& Dentistry) An unexpected research finding is providing information that could lead to new treatments of certain neurological diseases and disorders, including multiple sclerosis and Alzheimer's.Medical researcher Jason Plemel led a team that found immune cells in our brain and central nervous system, called microglia, interfere with blood immune cells called macrophages.This discovery suggests the immune cells in our brain and central nervous system are preventing the movement of the blood immune cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 30, 2020 Category: International Medicine & Public Health Source Type: news

FDA OKs trials for MS PET tracer
The U.S. Food and Drug Administration (FDA) has approved human trials for a...Read more on AuntMinnie.comRelated Reading: Novel PET agent could advance neurological imaging New PET radiotracer offers insight into multiple sclerosis SNMMI: PET helps track neuroinflammation in MS (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 29, 2020 Category: Radiology Source Type: news

Exoskeleton Could Support Enhanced Physical Therapy in MS Exoskeleton Could Support Enhanced Physical Therapy in MS
Expanding the potential uses of an exoskeleton to enhance rehabilitation in people with neuromuscular disabilities, researchers are studying the device in people with advanced multiple sclerosis.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 29, 2020 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Quintana Awarded the 2019 Barancik Prize for Innovation in Multiple Sclerosis Research
Francisco J. Quintana, PhD, Professor of Neurology at the Ann Romney Center for Neurologic Diseases, will receive the 2019 Barancik Prize for Innovation in Multiple Sclerosis Research from the National Multiple Sclerosis Society. This award recognize (Source: BWH News)
Source: BWH News - January 28, 2020 Category: Hospital Management Source Type: news

St. Michael’s receives federal funding for projects about multiple sclerosis, obesity, diabetes and HPV
(Source: St. Michael's Hospital News and Media)
Source: St. Michael's Hospital News and Media - January 27, 2020 Category: Hospital Management Tags: Hospital News Source Type: news

Vigorous cool room treadmill training to improve walking ability in people with multiple sclerosis who use ambulatory assistive devices: a feasibility study - Devasahayam AJ, Chaves AR, Lasisi WO, Curtis ME, Wadden KP, Kelly LP, Pretty R, Chen A, Wallack EM, Newell CJ, Williams JB, Kenny H, Downer MB, McCarthy J, Moore CS, Ploughman M.
BACKGROUND: Aerobic training has the potential to restore function, stimulate brain repair, and reduce inflammation in people with Multiple Sclerosis (MS). However, disability, fatigue, and heat sensitivity are major barriers to exercise for people with MS... (Source: SafetyLit)
Source: SafetyLit - January 27, 2020 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

New drug that could aid MS diagnoses approved for human trials by FDA
(Case Western Reserve University) A new drug that could make it easier for doctors to diagnose multiple sclerosis (MS) in its earlier stages has been approved for its first human trials by the US Food and Drug Administration (FDA). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 27, 2020 Category: International Medicine & Public Health Source Type: news

Don't cut salt completely: Study discovers that high-salt diets inhibit tumor growth
(Natural News) Having too much salt in your diet is incredibly unhealthy. High-salt intake can exacerbate conditions like multiple sclerosis and inflammatory bowel diseases. However, when it comes to cancer, a team of researchers is now suggesting that increasing the amount of salt in your diet may have some beneficial effects, particularly when it comes to fighting... (Source: NaturalNews.com)
Source: NaturalNews.com - January 25, 2020 Category: Consumer Health News Source Type: news

The highways of our brain
(Netherlands Institute for Neuroscience - KNAW) Researcher of the Netherlands Institute for neuroscience found that myelin, the sheath around neurons, creates a coaxial cable producing multiple waves of electrical potentials traveling in a more complicated manner than was envisioned earlier. These findings allow us to create better theories and tools to understand demyelinating diseases, including the most common neurological disorder, multiple sclerosis. The paper has been published in the prestigious scientific journal Cell. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 24, 2020 Category: International Medicine & Public Health Source Type: news

Living near major roads linked to risk of dementia, Parkinson's, Alzheimer's and MS
(University of British Columbia) Living near major roads or highways is linked to higher incidence of dementia, Parkinson's disease, Alzheimer's disease and multiple sclerosis (MS), suggests new research published this week in the journal Environmental Health. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 23, 2020 Category: International Medicine & Public Health Source Type: news

Don't cut salt completely: Animal study discovers that high-salt diets can inhibit tumor growth
(Natural News) Having too much salt in your diet is incredibly unhealthy. High-salt intake can exacerbate conditions like multiple sclerosis and inflammatory bowel diseases. However, when it comes to cancer, a team of researchers is now suggesting that increasing the amount of salt in your diet may have some beneficial effects, particularly when it comes to fighting... (Source: NaturalNews.com)
Source: NaturalNews.com - January 20, 2020 Category: Consumer Health News Source Type: news

From depression to dementia, inflammation is medicine ’s new frontier | Edward Bullmore
The barrier between mind and body appears to be crumbling. Clinical practice and public perception need to catch upUnlikely as it may seem, #inflammation has become a hashtag. It seems to be everywhere suddenly, up to all sorts of tricks. Rather than simply being on our side, fighting infections and healing wounds, it turns out to have a dark side as well: the role it plays in causing us harm.It ’s now clear that inflammation is part of the problem in many, if not all, diseases of the body. And targeting immune or inflammatory causes of disease has led to a series of breakthroughs, from new treatments for rheumatoid ...
Source: Guardian Unlimited Science - January 19, 2020 Category: Science Authors: Edward Bullmore Tags: Mental health Psychiatry Multiple sclerosis Depression Dementia Society Medical research Science UK news Alzheimer's Parkinson's disease Schizophrenia Source Type: news

Robotic 'trousers' could help thousands of multiple sclerosis sufferers stand and walk again
The robo-legs are being tested by 20 people with MS as part of a study at Kent and Canterbury Hospital. One MS patient to benefit from the trial is Richard Aske-Haley. (Source: the Mail online | Health)
Source: the Mail online | Health - January 18, 2020 Category: Consumer Health News Source Type: news

Biofeedback based home balance training can improve balance but not gait in people with multiple sclerosis - Novotna K, Janatova M, Hana K, Svestkova O, Preiningerova Lizrova J, Kubala Havrdova E.
BACKGROUND: Impaired balance is common in people with multiple sclerosis (MS) and can be present even in those with a mild disability level. With increasing disability, gait, and balance impairment progress, and lead to increased risk of falls. In some rec... (Source: SafetyLit)
Source: SafetyLit - January 16, 2020 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

2011 to 2017 Saw Increase in Spending on DMTs for MS
WEDNESDAY, Jan. 15, 2020 -- From 2011 to 2017, there was an increase in gross annual expenditures on multiple sclerosis (MS) disease-modifying therapies (DMTs), with increased spending mainly driven by increases in per-prescription costs, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 15, 2020 Category: Pharmaceuticals Source Type: news

Prices of MS Medications Keep Soaring
WEDNESDAY, Jan. 15, 2020 -- The cost of essential medications for multiple sclerosis have nearly tripled this decade, despite the release of the first generic MS drug, a new study shows. The 2015 release of glatiramer acetate -- the generic version... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 15, 2020 Category: General Medicine Source Type: news

Type of Herpes Virus Tied to Multiple Sclerosis
A study of 16,000 people suggests that human herpesvirus 6A is a risk factor for developing multiple sclerosis, reinvigorating a neglected hypothesis that the virus could be involved in triggering... (Source: The Scientist)
Source: The Scientist - January 10, 2020 Category: Science Tags: News & Opinion Source Type: news

First Direct Comparison of Stem Cells vs Drugs in MS Underway First Direct Comparison of Stem Cells vs Drugs in MS Underway
The first trial that will directly compare the safety and efficacy of stem cell transplantation to the best available drugs in the treatment of relapsing remitting multiple sclerosis has launched.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 10, 2020 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Mayo Clinic discovers a molecular switch for repairing central nervous system disorders
(Mayo Clinic) A molecular switch has the ability to turn on a substance in animals that repairs neurological damage in disorders such as multiple sclerosis (MS), Mayo Clinic researchers discovered. The early research in animal models could advance an already approved Food and Drug Administration therapy and also could lead to new strategies for treating diseases of the central nervous system. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 10, 2020 Category: International Medicine & Public Health Source Type: news

Primary Progressive MS: That 10% Primary Progressive MS: That 10%
Patients and doctors see signs of progress in a relentless form of multiple sclerosis.Medscape Neurology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 9, 2020 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news

MyHealthTeams launches new resources for pregnant women with MS
The new tool was designed in partnership with EMD Serono, and aims to give expecting moms information about managing multiple sclerosis during pregnancy.   (Source: mobihealthnews)
Source: mobihealthnews - January 9, 2020 Category: Information Technology Source Type: news

New Multiple Sclerosis Treatment Clinical Trial Begins Enrollment
Clinical trial of Autologous Hematopoietic Stem Cell Transplantation versus Best Available Therapy for Multiple Sclerosis (BEAT-MS) begins enrollment (Source: Disabled World)
Source: Disabled World - January 7, 2020 Category: Disability Tags: Clinical Trials Source Type: news

New multiple sclerosis treatment trial compares stem cell transplantation to best available drugs
NIH-funded study focuses on severe forms of relapsing MS. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - January 7, 2020 Category: American Health Source Type: news

New MS treatment trial compares stem cell transplantation to best available drugs
(NIH/National Institute of Allergy and Infectious Diseases) A clinical trial has begun testing an experimental stem cell treatment against the best available biologic therapies for severe forms of relapsing multiple sclerosis (MS). The trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will compare the safety, efficacy and cost-effectiveness of the two therapeutic approaches. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 7, 2020 Category: International Medicine & Public Health Source Type: news

Is omega-3 supplementation an effective alternative treatment for multiple sclerosis (MS)?
(Natural News) Omega-3 fatty acids may offer a natural approach to treat the symptoms of multiple sclerosis (MS). The nutrients may come from either health supplements or foods rich in fatty acids. Multiple sclerosis is a severe neurodegenerative disease. There is no cure, and no one knows what triggers the autoimmune response. Each patient with... (Source: NaturalNews.com)
Source: NaturalNews.com - January 3, 2020 Category: Consumer Health News Source Type: news

Is a wearable sensor-based characterisation of gait robust enough to overcome differences between measurement protocols? A multi-centric pragmatic study in patients with multiple sclerosis - Angelini L, Carpinella I, Cattaneo D, Ferrarin M, Gervasoni E, Sharrack B, Paling D, Nair KPS, Mazz à C.
Inertial measurement units (IMUs) allow accurate quantification of gait impairment of people with multiple sclerosis (pwMS). Nonetheless, it is not clear how IMU-based metrics might be influenced by pragmatic aspects associated with clinical translation of... (Source: SafetyLit)
Source: SafetyLit - December 31, 2019 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Marijuana Use for MS Tied to Legal Permissiveness
FRIDAY, Dec. 27, 2019 -- Cannabis use among patients with multiple sclerosis (MS) is more likely where cannabis laws are more permissive, according to a study published in the February issue of Multiple Sclerosis and Related Disorders. Andrea... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 27, 2019 Category: Pharmaceuticals Source Type: news

From Flame to Inflammation: How Smoking Likely Worsens MS From Flame to Inflammation: How Smoking Likely Worsens MS
Researchers evaluate the evidence to explain why cigarette smoking is particularly risky among people with multiple sclerosis.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - December 25, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Psychological resilience and vulnerability as mediators between adverse life events and fatigue, motor dysfunction and paraesthesiae in multiple sclerosis - Swanepoel I, van Staden W, Fletcher L.
This study examined the role of psychological resilienc... (Source: SafetyLit)
Source: SafetyLit - December 24, 2019 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Diets and bone health: Can eating red meat prevent multiple sclerosis?
(Natural News) The link between certain diets and multiple sclerosis (MS) is an area of great interest among members of the MS community. While there are already established studies that point towards the beneficial effects of certain foods and dietary components like omega-3 fatty acids, there is not enough research to make a solid consensus... (Source: NaturalNews.com)
Source: NaturalNews.com - December 21, 2019 Category: Consumer Health News Source Type: news

Prospective memory key to performance of everyday life activities in multiple sclerosis
(Kessler Foundation) 'Poor prospective memory hinders the ability to perform a broad range of everyday life activities, which undermines individuals' independence,' noted Dr. Weber. 'Our findings indicate that developing strategies that improve time-based functioning may help individuals with MS improve their prospective memory and support their efforts to maintain their independence.' (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 20, 2019 Category: International Medicine & Public Health Source Type: news

Critically appraised paper: Task-oriented gait training that focuses on the safe and correct use of a walking aid may reduce falls in people with multiple sclerosis [synopsis] - Plummer P.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - December 19, 2019 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news